{"url":"https://lda.senate.gov/api/v1/filings/9078018a-fa54-41ce-b351-e6fcde3070a0/","filing_uuid":"9078018a-fa54-41ce-b351-e6fcde3070a0","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2024,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.senate.gov/filings/public/filing/9078018a-fa54-41ce-b351-e6fcde3070a0/print/","filing_document_content_type":"text/html","income":null,"expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Joel White","dt_posted":"2024-10-10T15:59:21-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"440 First St., NW","registrant_address_2":"Suite 430","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20001","registrant":{"id":315592,"url":"https://lda.senate.gov/api/v1/registrants/315592/","house_registrant_id":39410,"name":"HORIZON GOVERNMENT AFFAIRS","description":"Health Care and Health Care Coverage","address_1":"440 First St., NW","address_2":"Suite 430","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20001","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"JOEL WHITE","contact_telephone":"+1 202-808-8856","dt_updated":"2026-07-15T19:32:46.215715-04:00"},"client":{"id":45186,"url":"https://lda.senate.gov/api/v1/clients/45186/","client_id":45186,"name":"LABORATORY ACCESS & BENEFITS (LAB) COALITION","general_description":"Coaltion to drive the future of laboratory and diagnostic testing policies","client_government_entity":null,"client_self_select":false,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2022-02-01"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Issues related to laboratory testing, reimbursement, access, benefits, and value. At-home testing. Issues relating to the Protecting Access to Medicare Act (PAMA) and the clinical laboratory fee schedule including the Telehealth Modernization Act (H.R. 7623). Regulation of laboratory-developed tests, including the FDAs final rule, Docket No. FDA-2023-N-2177. Issues relating to value-based arrangements for lab testing. Issues related to the use of artificial intelligence in health care.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":80647,"prefix":null,"prefix_display":null,"first_name":"BRETT","nickname":null,"middle_name":null,"last_name":"MEEKS","suffix":null,"suffix_display":null},"covered_position":"Former Deputy Health Policy Director for the Senate Committee on Health, Education, Labor and Pensions","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}